\Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global HIV Diagnostics Market, by Product
1.1.2. Global HIV Diagnostics Market, by Test Type
1.1.3. Global HIV Diagnostics Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown of Primary Respondents
3.5. Forecasting Test Types
3.6. Research Methodology for Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
5.3. Impact of COVID 19 on HIV Diagnostics Market
5.3.1. Impact on Market Value in 2023 and 2021
5.3.2. Clinical Trial Impact
5.3.3. Impact of Demand
5.3.4. Strategies to Overcome the challenges
6. GLOBAL HIV DIAGNOSTICS MARKET, BY PRODUCT
6.1. Overview
6.2. Consumables
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
6.2.1. Assays and Kits & Reagents
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
6.2.2. Other Consumables
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
6.3. Instruments
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
6.4. Software & Services
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7. GLOBAL HIV DIAGNOSTICS MARKET, BY TEST TYPE
7.1. Overview
7.2. Antibody Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.1. HIV-1 Screening Test
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.1.1. Elisa
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.1.2. Rapid Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.1.3. Home Access Dried Blood Spots
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.2. HIV-1 Antibody Confirmatory Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.2.1. Western Blot Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.2.2. Indirect Immunofluorescence Assays (IFA)
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.2.3. Line Immunoassay
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.2.4. Radio-Immunoprecipitation Assays
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.2.3. HIV-2 & Group O Diagnostic Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.3. Viral Load Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.4. CD4 Tests
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.5. Tests for Early Infant Diagnosis
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
7.6. Tests for Viral Identification
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
8. GLOBAL HIV DIAGNOSTICS MARKET, BY END USER
8.1. Overview
8.2. Diagnostic Laboratories
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
8.3. Hospitals
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
8.4. Blood Banks
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
8.5. Others
Market Estimates & Forecast, by Region, 2023โ2030
Market Estimates & Forecast, by Country, 2023โ2030
9. GLOBAL HIV DIAGNOSTICS MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitor Dashboard
10.3. Major Growth Strategy in the Global HIV Diagnostics Market
10.4. Competitive Benchmarking
10.5. The Leading Player in terms of Number of Developments in the Global HIV Diagnostics Market
10.6. Key Developments & Growth Strategies
10.6.1. New Product Launch/Service Deployment
10.6.2. Merger & Acquisition
10.6.3. Joint Ventures
10.7. Major Players Financial Matrix & Market Ratio
10.7.1. Sales & Operating Income 2019
10.7.2. Major Players R&D Expenditure 2019
11. COMPANY PROFILES
11.1. Siemens Healthineers (A Division of Siemens AG)
11.1.1. Company Overview
11.1.2. Products/Services Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Roche Diagnostics (Division of Hoffman La Roche Ltd.)
11.3. Abbott Laboratories
11.4. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.5. Thermo-Fisher Scientific Inc.
11.6. Merck KGaA
11.7. Becton, Dickinson & Company
11.8. Hologic Inc.
11.9. Alere Inc.
11.10. Bio-Rad Laboratories
11.11. Others
12. APPENDIX
12.1. References
12.2. Related Reports
NOTE:
This table of content is tentative and subject to change as the research progresses.
๏ก ๏ก In section 11, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.
๏ก ๏ก Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.
LIST OF TABLES
TABLE 1 GLOBAL HIV DIAGNOSTICS MARKET SYNOPSIS, 2017โ2030
TABLE 2 GLOBAL HIV DIAGNOSTICS MARKET ESTIMATES & FORECAST, 2023โ2030 (USD MILLION)
TABLE 3 GLOBAL HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 4 GLOBAL HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 5 GLOBAL HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 6 GLOBAL HIV DIAGNOSTICS MARKET, BY REGION, 2023โ2030 (USD MILLION)
TABLE 7 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 8 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 9 NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 10 US: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 11 US: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 12 US: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 13 CANADA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 14 CANADA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 15 CANADA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 16 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 17 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 18 LATIN AMERICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 19 EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 20 EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 21 EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 22 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 23 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 24 WESTERN EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 25 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 26 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 27 EASTERN EUROPE: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY PRODUCT, 2023โ2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY TEST TYPE, 2023โ2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET, BY END USERS, 2023โ2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HIV DIAGNOSTICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HIV DIAGNOSTICS MARKET
FIGURE 4 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2019 (%)
FIGURE 5 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY TEST TYPE, 2019 (%)
FIGURE 6 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY END USERS, 2019 (%)
FIGURE 7 GLOBAL HIV DIAGNOSTICS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 8 AMERICAS: HIV DIAGNOSTICS MARKET SHARE BY REGION, 2019 (%)
FIGURE 9 NORTH AMERICA: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 10 EUROPE: HIV DIAGNOSTICS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 11 WESTERN EUROPE: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 12 ASIA-PACIFIC: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 13 MIDDLE EAST & AFRICA: HIV DIAGNOSTICS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 14 GLOBAL HIV DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)
FIGURE 15 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): KEY FINANCIALS
FIGURE 16 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): SEGMENTAL REVENUE
FIGURE 17 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG): REGIONAL REVENUE
FIGURE 18 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.): KEY FINANCIALS
FIGURE 19 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.).: SEGMENTAL REVENUE
FIGURE 20 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.): REGIONAL REVENUE
FIGURE 21 ABBOTT LABORATORIES: KEY FINANCIALS
FIGURE 22 ABBOTT LABORATORIES: SEGMENTAL REVENUE
FIGURE 23 ABBOTT LABORATORIES: REGIONAL REVENUE
FIGURE 24 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): KEY FINANCIALS
FIGURE 25 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): SEGMENTAL REVENUE
FIGURE 26 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION): REGIONAL REVENUE
FIGURE 27 THERMO-FISHER SCIENTIFIC INC.: KEY FINANCIALS
FIGURE 28 THERMO-FISHER SCIENTIFIC INC.: SEGMENTAL REVENUE
FIGURE 29 THERMO-FISHER SCIENTIFIC INC.: REGIONAL REVENUE
FIGURE 30 MERCK KGAA: KEY FINANCIALS
FIGURE 31 MERCK KGAA: SEGMENTAL REVENUE
FIGURE 32 MERCK KGAA: REGIONAL REVENUE
FIGURE 33 BECTON, DICKINSON & COMPANY: KEY FINANCIALS
FIGURE 34 BECTON, DICKINSON & COMPANY: SEGMENTAL REVENUE
FIGURE 35 BECTON, DICKINSON & COMPANY: REGIONAL REVENUE
FIGURE 36 HOLOGIC INC.: KEY FINANCIALS
FIGURE 37 HOLOGIC INC.: SEGMENTAL REVENUE
FIGURE 38 HOLOGIC INC.: REGIONAL REVENUE
FIGURE 39 ALERE INC.: KEY FINANCIALS
FIGURE 40 ALERE INC.: SEGMENTAL REVENUE
FIGURE 41 ALERE INC.: REGIONAL REVENUE
FIGURE 42 BIO-RAD LABORATORIES.: KEY FINANCIALS
FIGURE 43 BIO-RAD LABORATORIES.: SEGMENTAL REVENUE
FIGURE 44 BIO-RAD LABORATORIES.: REGIONAL REVENUE